NCT02763124View on ClinicalTrials.gov

Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Astigmatism
Interventions
PROCEDURE

Verion-LenSx

The Verion-LenSx femtosecond laser system will be used to create one or two partial-depth corneal arcuate incisions

Trial Locations (1)

30501

Gainesville Eye Associates, Gainesville

All Listed Sponsors
collaborator

Alcon, a Novartis Company

INDUSTRY

lead

Gainesville Eye Associates

OTHER

NCT02763124 - Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions | Biotech Hunter | Biotech Hunter